Quantcast

Latest Hurler Syndrome Stories

2009-09-30 15:00:00

NOVATO, Calif., Sept. 30 /PRNewswire-FirstCall/ --BioMarin Pharmaceutical Inc.

2009-09-30 08:00:00

NOVATO, Calif., Sept. 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, October 28, at 5:00 p.m.

2009-09-22 15:00:00

NOVATO, Calif., Sept. 22 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the first patient has initiated treatment in the Phase 2 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU).

2009-09-08 08:00:00

NOVATO, Calif., Sept. 8 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2009-09-02 08:00:00

NOVATO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jeffrey H.

2009-09-02 08:00:00

NOVATO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2009-08-19 08:00:00

NOVATO, Calif., Aug. 19 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2009-07-30 15:05:00

NOVATO, Calif., July 30 /PRNewswire-FirstCall/ -- Financial Highlights ($ in millions, except per share data) Item Q2 2009 Q2 2008 Comparison Total BioMarin Revenue $82.8 29% increase Total Net Product Revenue $81.5 35% increase Naglazyme Net Product Revenue $42.9 22% increase Aldurazyme Net Sales by Genzyme $39.2 1% increase...

2009-07-30 15:00:00

NOVATO, Calif., July 30, /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2009-07-13 08:00:00

NOVATO, Calif., July 13 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.